Table 5.
Summary of all growth factors used in the studies systematically reviewed
| Growth Factor Drug/Growth Factor | Number of Studies | References |
|---|---|---|
| SDF-1-alpha | 8 | 42,50,51,65,74,102,144,145 |
| VEGF | 8 | 65,83,102,146–150 |
| bFGF/FGF | 11 | 55,65,83,102,147,151–156 |
| Human epidermal growth factor | 4 | 157–160 |
| Neutrophin-3 | 1 | 161 |
| Angiopoietin-1 | 1 | 43 |
| Conditioned media | 6 | 85,87,89–91,161,162 |
| Glucose oxidase | 1 | 163 |
| Platelet-rich plasma/platelet lysate | 4 | 46,164–166 |
| Hepatocyte growth factor | 1 | 166 |
| Platelet-derived growth | 4 | 55,65,83,167 |
| TNF | 2 | 65,102 |
| Thrombin | 1 | 168 |
| Substance P | 2 | 84,169 |
| Other | 14 | 45,56,72,84,97,102,103,152,170–175 |
bFGF, basic fibroblast growth factor; SDF, stromal-derived growth factor.